Pearl Therapeutics, Inc.
42 clinical trials · Sponsor
◉ Watch Pearl Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| To Assess the Efficacy and Safety of PT010 Compared to PT009 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (NCT03081247) | Pearl Therapeutics, Inc. | 2018-04-16 |
| Efficacy and Safety of PT001 to Placebo and Open-label Spiriva® Respimat® in Subjects With Persistant Asthma (NCT03358147) | Pearl Therapeutics, Inc. | 2017-12-13 |
| A Randomized, Open-label, Single-dose, Single-center, Crossover Study in Healthy Subjects to Assess the Relative Bioavailability of PT010 (NCT03311373) | Pearl Therapeutics, Inc. | 2017-10-17 |
Track Pearl Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.